SEDANA — Sedana Medical AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK1.03bn
- SEK839.10m
- SEK178.75m
- 26
- 25
- 44
- 19
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.07 | ||
| Price to Tang. Book | 4.51 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.75 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -5.25% | ||
| Return on Equity | -1.11% | ||
| Operating Margin | -28.4% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 141.77 | 159.15 | 122.86 | 153.87 | 178.75 | 209 | 260 | 20.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
Directors
- Thomas Eklund CHM (53)
- Johannes Doll CEO (40)
- Susanne Andersson CFO (51)
- Peter Sackey CTO (49)
- Robert Vom Dorp DSL (50)
- Sylvia Eriksson DHR (53)
- Ron Farrell OTH (64)
- Stefan Krisch OTH (47)
- Christoffer Rosenblad DRC (46)
- Sten Gibeck IND (77)
- Bengt Julander IND (68)
- Ola Magnusson IND (72)
- Eva Walde IND (58)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 10th, 2004
- Public Since
- June 21st, 2017
- No. of Shareholders
- 7,575
- No. of Employees
- 74
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 99,336,960
- Address
- Vendevagen 89, DANDERYD, 182 32
- Web
- https://sedanamedical.com/
- Phone
- +46 812405200
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for SEDANA
Q1 2025 Sedana Medical AB (publ) Earnings Call
Sedana Medical AB (publ) Annual Shareholders Meeting
Sedana Medical AB (publ) Annual Shareholders Meeting
Q2 2025 Sedana Medical AB (publ) Earnings Release
Q3 2025 Sedana Medical AB (publ) Earnings Release
Similar to SEDANA
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Sedana Medical AB (publ) share price?
As of Today at 23:09 UTC, shares in Sedana Medical AB (publ) are trading at SEK10.34. This share price information is delayed by 15 minutes.
How has the Sedana Medical AB (publ) share price performed this year?
Shares in Sedana Medical AB (publ) last closed at SEK10.34 and the price had moved by -45.35% over the past 365 days. In terms of relative price strength the Sedana Medical AB (publ) share price has underperformed the FTSE Global All Cap Index by -46.72% over the past year.
What are the analyst and broker recommendations for Sedana Medical AB (publ)?
The overall consensus recommendation for Sedana Medical AB (publ) is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Sedana Medical AB (publ) dividend yield?
Sedana Medical AB (publ) does not currently pay a dividend.
Does Sedana Medical AB (publ) pay a dividend?
Sedana Medical AB (publ) does not currently pay a dividend.
When does Sedana Medical AB (publ) next pay dividends?
Sedana Medical AB (publ) does not currently pay a dividend.
How do I buy Sedana Medical AB (publ) shares?
To buy shares in Sedana Medical AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sedana Medical AB (publ)?
As of the previous close price of SEK10.34, shares in Sedana Medical AB (publ) had a market capitalisation of SEK1.03bn.
Where are Sedana Medical AB (publ) shares listed?
Here are the trading details for Sedana Medical AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: SEDANA
What kind of share is Sedana Medical AB (publ)?
Based on an overall assessment of its quality, value and momentum Sedana Medical AB (publ) is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sedana Medical AB (publ) share price forecast for 2025?
The analyst consensus target price for shares in Sedana Medical AB (publ) is SEK24.00. That is 132.11% above the last closing price of SEK10.34.
Analysts covering Sedana Medical AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.23 for the next financial year.
Find out moreWhat is the trend in the Sedana Medical AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sedana Medical AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -30.88%.
As of the last closing price of SEK10.34, shares in Sedana Medical AB (publ) were trading -41.7% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sedana Medical AB (publ) PE Ratio?
The Sedana Medical AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK10.34.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sedana Medical AB (publ)?
Sedana Medical AB (publ)'s management team is headed by:
- Thomas Eklund - CHM
- Johannes Doll - CEO
- Susanne Andersson - CFO
- Peter Sackey - CTO
- Robert Vom Dorp - DSL
- Sylvia Eriksson - DHR
- Ron Farrell - OTH
- Stefan Krisch - OTH
- Christoffer Rosenblad - DRC
- Sten Gibeck - IND
- Bengt Julander - IND
- Ola Magnusson - IND
- Eva Walde - IND